Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Voting Rights and Shares Capital of the Company
In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)PARIS, April10, 2024(GLOBE NEWSWIRE) --Market: Euronext Paris / Nasdaq Euronext Compartment: BISIN code: FR0011341205 Nasdaq: NBTX Bloomberg: NANO:FP Reuters: NANO.PA Website:www.nanobiotix.comDate Number of Shares OutstandingTotal number of voting rightsTotal voting rights, ...
Nasdaq GlobeNewswire
10/04/2024
Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program…
Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program Eleventh tranche fully issued and paid-up Leuven, BELGIUM, 10 April 2024 – 07.00 PM CET– Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, today communicates it has received an aggregate amount of EUR 450,000 in the framework of the Atlas Funding Program. On April 10, 2024, the Company issued the Eleventh Tranche consisting of 18 convertible bonds, for an aggregate amount of...
Nasdaq GlobeNewswire
10/04/2024
OSE Immunotherapeutics Receives €8.4 M in Public Funding to Support the…
OSE Immunotherapeutics Receives €8.4 M in Public Fundingto Support the Registration Phase 3 Clinical Trialof Cancer Vaccine Tedopi® in Lung Cancer Nantes, France – April 10, 2024 – 6:00 pm CET –OSE ImmunotherapeuticsSA (ISIN: FR0012127173; Mnemo: OSE)today announced the Company has received €8.4 million in non-dilutive funding under the “i-Démo” call for projects as part of the plan “France 2030” operated by Bpifrance on behalf of the State. This plan aims at...
Nasdaq GlobeNewswire
10/04/2024
EUROBIO SCIENTIFIC: 2023 ANNUAL RESULTS
2023 ANNUAL RESULTS Growth in Core Business and strategic deployment Core business1 revenues up 39% to €130mproprietary products account for 30% of revenues38% of revenues generated outside FranceResilient results within a strategic transformation phaseFree cash flow of €26.4mNet financial debt reduced to €5.5m, with €89m cash positionParis, April 10, 2024 - 5.40pm - Eurobio Scientific(FR0013240934, ALERS), a leading French group inin vitromedical...
Nasdaq GlobeNewswire
10/04/2024
Major shareholder announcement – BlackRock, Inc.
ANNOUNCEMENT NO. 260Major shareholder announcementMajor shareholder announcement – BlackRock, Inc. Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec A/S that BlackRock Investment Management (UK) Limited on 9 April 2024, increased its holding of voting rights attached to shares and voting rights in ChemoMetec A/S to above 10%, and that the holding thus exceeds the 10 per cent limit in section 38 of...
Nasdaq GlobeNewswire
10/04/2024
CSafe unveils cutting-edge innovations to meet cold chain customer needs
"2024 marks a bold year of innovation for CSafe—we're redefining the landscape of cold chain logistics," said Patrick Schafer, CSafe CEO. "We're constantly listening to our customers, and that ensures we're able to meet their current needs and anticipate and address their future challenges." " 2024 marksa bold year of innovation for CSafe—we're redefining the landscape of cold chain logistics," saidPatrick Schafer, CSafe CEO. "We're constantly listening to our…
PR Newswire
10/04/2024
Healthcare Analytical Testing Services Market Worth $12.6 billion |…
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=108923833 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=108923833 Browse in-depth TOC on "Healthcare Analytical Testing Services Market" 385 - Tables 65 - Figures 408 - Pages Healthcare Analytical Testing Services Market Scope: Cell cell-based assay testing service segment is expected to register the substantial share by type of...
PR Newswire
10/04/2024
Global Circular Fashion Market to reach $11 billion, globally, by 2030 growing…
Market Dynamics: Market Dynamics : The growth of the circular fashion market can be attributed to increasing consumer awareness towards sustainable fashion practices and the rising demand for environmentally friendly clothing. Additionally, government initiatives promoting sustainable fashion and the implementation of strict regulations regarding waste management in the textile industry are driving the market growth further. Global Circular Fashion Market Report Coverage •...
PR Newswire
10/04/2024
Cyspera® Celebrates Triple Triumph in Prestigious Beauty Awards Across US and…
Dr. Amy Lewis, a fervent advocate of Cyspera's innovative approach, shared her enthusiasm for the product's efficacy, stating, "I use Cyspera®'s award-winning formula with the innovative Cysteamine Isobionic-Amide Complex every day and I've witnessed unparalleled efficacy in my practice. I also find it very convenient to combine it with other treatment modalities and procedures and it is changing the paradigm on how we can solve hyperpigmentation today". Dr.Amy Lewis, a fervent…
PR Newswire
10/04/2024
Software Segment of Global A.I. Healthcare Billion Dollar Market Expected to…
It continued: "To understand which therapeutic areas have most AI support, let's take a look at the FDA-approved list of AI-enabled applications. FDA approved 521 devices using AI, according to the last update from FDA.gov. Radiology has 75%, or 391 FDA cleared devices. This report shows us that radiological imaging has become very promising and usable in practice. Based on components, the global AI in the healthcare market can be divided into software, hardware, and services. The software…
PR Newswire
10/04/2024
AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data…
AIM ImmunoTech Inc.(NYSE American: AIM) (“AIM”) today announced top-line interim data indicating that combining Ampligen (rintatolimod) with Keytruda (pembrolizumab) in the treatment of recurrent ovarian cancer may have a powerful synergistic effect, leading the investigator to conclude that the combination therapy could be far more effective than pembrolizumab alone as a therapy for the disease. See further details on the study “Systemic Immune Checkpoint Blockade and Intraperitoneal...
Nasdaq GlobeNewswire
10/04/2024
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR…
Large-scale contraception or sterilization plays a major role in the commercial aquaculture industry. As female fish mature, they put the majority of their energy into egg production, instead of muscle growth, which reduces the potential weight gain. Additionally, farm-raised fish that escape may breed with their wild counterparts and produce offspring that are less suited to surviving in the wild. Growing reproductively contracepted or sterile fish is the most effective way to manage these…
PR Newswire
10/04/2024
Screen Printed Glass Market to Reach $1,500.1 Billion, Globally, by 2032 at 5.3%…
Prime determinants of growth Prime determinants of growth The growth of the global screen printed glass market is driven by factors such as increase in demand for customization and rise in infrastructure development. However, high costs and availability of alternatives restrict the market growth. On the contrary, expansion opportunities in emerging markets and increasing focus towards energy-efficiency are expected to offer new opportunities in the coming years. Report coverage &...
PR Newswire
10/04/2024
Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia…
"Rarely has the timing of a project been better than in this case; while within schizophrenia research we are uncovering several new connections between schizophrenia and the GABA system, the collaboration with Gabather gives us the opportunity to test the clinical significance of actively influencing the GABA system in patients with schizophrenia. If our studies show positive results, the collaboration will provide optimal conditions to quickly proceed with necessary additional studies…
PR Newswire
10/04/2024
Arc Welding Torch Market worth $3.5 billion by 2029 - Exclusive Report by…
Browse in-depth TOC on "Arc Welding Torch Market" Browse in-depth TOC on "Arc Welding Torch Market" 269 – Tables 65 – Figures 284 – Pages Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=168715824 "Electrodes segment is estimated to be the largest wear part segment of arc welding torch." Electrodes are essential components in arc welding, serving as the source of the welding arc and the material that is melted to create the weld...
PR Newswire
10/04/2024
Global Immunomodulator Market Valuation Set to Total a Staggering US$ 178…
Over the next ten years, a robust CAGR of 7.2% has been predicted for the market. By 2034, immunomodulator sales are projected to total a staggering valuation of US$ 178.0 billion. Over the next ten years, a robust CAGR of7.2%has been predicted for the market. By 2034, immunomodulator sales are projected to total a staggering valuation of US$ 178.0 billion . Demand remains particularly high for immunosuppressants owing to their increasing usage in managing various autoimmune disorders...
PR Newswire
10/04/2024
Global Licorice Root Market to reach a valuation of US$ 2,002.1 million by 2034…
Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-3135 Download the Sample PDF report to explore key market insights and trends:https://www.futuremarketinsights.com/reports/sample/rep-gb-3135 Ongoing research and development activities focused on exploring the therapeutic properties and potential applications of licorice root are expanding the market opportunities, which includes studies on its...
PR Newswire
10/04/2024
3Shape Charts Sustainable Course with Release of Comprehensive Sustainability…
The report details 3Shape's sustainability strategy, steps taken so far, and achievements to date in areas such as climate action, pollution, diversity and inclusion, employee wellbeing, responsibility towards consumers and end-users, governance, and integrity. The report details 3Shape's sustainability strategy, steps taken so far, and achievements to date in areas such as climate action, pollution, diversity and inclusion, employee wellbeing, responsibility towards consumers and end-users,...
PR Newswire
10/04/2024
CAMH develops first ever clinically validated natural supplement to prevent…
Up to 8 out of ten new mothers experience postpartum, or 'baby,' blues, characterized by mood swings, crying spells, anxiety and difficulty sleeping. The condition usually begins within the first few days after delivery and may last for up to two weeks. Postpartum blues strongly raises the risk of postpartum depression, a serious mental illness affecting 13 per cent of mothers. Postpartum depression has important health care consequences: impairing quality of life, increasing risk for future…
PR Newswire
10/04/2024
Leading the Way: Nicklaus Children's Hospital Awarded Global Healthcare…
Dr. Andrea Maggioni, Director of Global Health at Nicklaus Children's Hospital, expressed deep satisfaction in the hospital's accreditation milestone, remarking, "Achieving a recognition of "Excellence in Medical Travel Services" by Global Healthcare Accreditation underscores our longstanding commitment to pediatric care and affirms our dedication to meeting the highest standards of quality and safety for traveling patients. We are immensely proud of our Global Health team's…
PR Newswire
10/04/2024
MGI Tech Crowned in GHP's Biotechnology Awards 2024 as the Most Innovative…
Global Health & Pharma Magazine (GHP) serves as a vital information hub for the healthcare and pharmaceutical industries. With a global circulation of 110,000, the UK based magazine holds deep respect for the groundbreaking research and intellect within the biotechnology sector. The annual Biotechnology Awards recognize companies at the forefront of innovation, driving progress in biotechnology. Global Health & Pharma Magazine (GHP) serves as a vital information hub for the healthcare…
PR Newswire
10/04/2024
ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in…
ACROBiosystems has successfully developed a multitude of organoids, including cardiac, cerebral, intestinal, liver organoids, along with toxicological evaluation models and disease models for Parkinson's, Alzheimer's, and inflammatory bowel disease. By leveraging its proprietary organoid research and development platform, the company is seeking to continuously expand its solutions by creating organoids like retina, skin, and lung; thereby broadening the scope of organoid applications. Through…
PR Newswire
10/04/2024
Readly joins the National Pharmacy Association's Your Health Your Pharmacy…
The campaign will reach over 3.4 million consumers in its first year with the goal of enhancing public health and reducing pressure on the National Health Service (NHS). Readly will contribute to the dissemination of health and wellness information through free access to its digital magazine and newspaper platform where health conscious consumers can read all the latest news, features and health and wellbeing tips from the 7,700 titles on the app. The campaign will reach over 3.4 million...
PR Newswire
10/04/2024
Gedeon Richter: Cariprazine has a real chance of becoming the best-selling…
Dr. István Greiner, Director of Richter's R&D recounted the story of cariprazine's development. "It was not a one-off success; we have already brought 9 original medicines to the market since World War II. From 1998, we started to focus on the brain's dopamine 3 receptor, and the efforts eventually resulted in cariprazine. It was approved by FDA in 2015 for schizophrenia – first in the history of the Hungarian pharmaceutical industry – later in the EU, and its indications extended in…
PR Newswire
10/04/2024
Altri Comunicati